RxDoctor Payments Data

Paul Mulvey, DO

Family Medicine · East Lansing, MINPI 1184003386

Payments from drug & device makers

$973in general payments, 2019–2025

Across 52 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$332
  • AbbVie$144
  • Boehringer Ingelheim$95
  • Lilly USA, LLC$65
  • Bayer$56
  • Axsome Therapeutics, Inc.$55
  • plus $226 from 10 others

What the payments were for

  • Food & beverage$973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$973 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$27,470
Medicare patients
86
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide69$83,926
EliquisApixaban63$63,138
OzempicSemaglutide23$52,836
JardianceEmpagliflozin23$36,959
JanuviaSitagliptin Phosphate12$18,265
RybelsusSemaglutide15$18,102
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog34$16,722
Tiotropium Bromide19$15,049
XareltoRivaroxaban13$12,367
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,758
Atorvastatin Calcium336$4,269
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$3,887
Levothyroxine Sodium338$3,550
Losartan Potassium257$2,961
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$2,914

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$65$83,92669 claims
Novo NordiskOzempic, Rybelsus$332$70,93838 claims
PfizerEliquis$47$63,13863 claims
Boehringer IngelheimJardiance$95$36,95923 claims
MerckJanuvia$22$18,26512 claims
AbbVieArmour Thyroid, Synthroid$144$3,52146 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →